TrialOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA2024
One versus 2 years of alendronate following denosumab: the CARD extension.
Joy N Tsai et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papertrialcites it